Provincial Science

Provincial Science is a Boston-based biotechnology company co-founded by synthetic biology pioneers James J. Collins and Timothy Lu, along with science journalist Michael Specter. The company is developing a platform for programmable medicines, which utilizes synthetic biology to create therapeutics capable of sensing and responding to specific biological signals within the body. A core component of the company's vision is the decentralization of biologic production, aiming to enable the local and distributed manufacturing of these smart medicines. By integrating logic-based circuits into drug design, Provincial Science seeks to develop therapies that activate only in the presence of disease-specific markers, potentially increasing efficacy while minimizing off-target effects. The company is currently in the pre-clinical stage, focusing on the advancement of its foundational technology and the translation of complex biological circuits into clinical applications.